Fundraising Fox
Pathway Bioventures
Venture capitalChicago · Pre-Seed–Series A · 5 people tracked
Find your way into Pathway Bioventures
1,685 people in our graph share verified history with the Pathway Bioventures team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Pathway Bioventures focuses on early-stage precision therapeutics companies working on breakthrough life sciences innovations to address important unmet medical needs. The firm backs entrepreneurs pursuing advances in human health through novel therapeutics.
Source: firm website, verified Aug 3, 2026.
Team · 5 people
from the firm's website & curated
Founder mafia
2 people who came through Pathway Bioventures went on to found or lead other companies.
What they invest in
from 15 of 18 portfolio companiesBiotech ×13Healthtech ×11Deep Tech ×6Medical Devices ×5AI & Machine Learning ×3Digital Health ×2Fintech ×1Hardware ×1
HQs:United States×11United Kingdom×2
Who they back
founder profiles across 11 portfolio companiesFounding team size:solo founder×32 founders×53 founders×24+ founders×1
Where their founders studiedfrom 16 founders with education data
Northwestern University ×2Purdue University ×2University of Oklahoma ×2Yale School of Medicine ×2
What their founders studiedfrom 16 founders with field-of-study data
Engineering ×8Life Sciences ×7Medicine ×4
Investments · 18 tracked
founders shown can be your intro pathBy year:2024 · 22023 · 12021 · 22018 · 16 dated
Cytovale develops microfluidic deformability cytometry technology for immune response diagnostics, with a focus on early detection and diagnosis in hospital settings.
BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US
Ajay Shah(Co-founder & CEO)inHenry Tse(Co-founder & Chief Technology Officer)inDino DiCarlo(Director, Promoter)
BoardLindy Fishburne(Director)inJack Fuchs(Director, Promoter)in
Co-investorsAlumni VenturesBasecamp FundBlackhorn VenturesBreakout LabsBreakout VenturesDolby Family Ventures+3 more
4BIO Capital is an investment firm focused on early-stage advanced therapies targeting chronic disease.
BiotechDeep TechLondon, GB
Afference develops neurotechnology that enables remote sensory perception through wearable devices, allowing people at a distance to share tactile sensations.
AI & Machine LearningDeep TechHardwareHealthtechCleveland, US
Jacob Segil(Co-founder & CEO)inDustin Tyler(Co-founder & CTO)in
BoardTaylor Hurst(Director)inTrevor Zimmerman(Director)in
Co-investorsAnthropy PartnersCWRU Technology VenturesEvolution VC PartnersHannah Grey VenturesJobsOhio VenturesKonvoy Ventures+6 more
Axonis Therapeutics is a biotechnology company developing small-molecule medicines that target KCC2, a mediator of inhibition in the brain, to treat neurological disorders such as epilepsy and pain.
BiotechDeep TechBoston, US
Shane V. Hegarty(Chief Scientific Officer & Co-Founder)inJoanna Stanicka(Chief Executive Officer, President & Co-Founder)inJeff Imbaro(Chief Operating Officer)inTiasha Shafiq(Chief of Staff)in
BoardCorey . Goodman(Director)inJonathan Leff(Director)in
Co-investorsvenBio PartnersMRL Ventures FundSofinnova VenturesCivilization Ventures Management, LlcCreative Destruction Lab (CDL)Hatteras Venture Partners+8 more
Cytospire Therapeutics develops multispecific antibodies and next-generation γδ T cell engagers designed to direct innate and adaptive immune effector cells as an alternative to CD3-based engagers.
BiotechHealthtech
Co-investorsCriteria Bio VenturesLifeArc VenturesMedical Incubator Japan K.K.Modi VenturesSound Bioventures
Dimension Bio is a biotechnology company developing regenerative therapeutics using its BioNidum platform, which combines materials science, 3D printing, and digital manufacturing to produce implantable and injectable biosynthetic scaffolds that promote tissue healing.
BiotechHealthtechMedical DevicesNew MaterialsChicago, US
Caralynn Nowinski Collens, M.D.(Co-founder & CEO)inRamille Shah, Ph.D.(Co-founder & CSO)Caralynn Collens(Executive Officer, Director)inCaralynn Nowinski Collens(Co-founder & CEO)inRamille Shah(Co-founder & CSO)Adam Jakus(Co-Founder)in
Co-investorsBetter Ventures Central LlcHAWKTAILLofty VenturesPortal InnovationsSolas BioVenturesAlumni Ventures+3 more
.png)
IpiNovyx Bio is a biotech company developing potent and selective immunoproteasome inhibitors to treat cancer, autoimmune, and inflammatory diseases.
BiotechHealthtechMedical DevicesWest Nyack, US
Gang Lin(Scientific Founder)Carl Nathan(Scientific Founder)Franck Barrat(Scientific Founder)inMarc Appel(Executive Officer, Director)Lutz Giebel(Director)James Graham(Director)
Co-investorsAlexandria
miRecule is a biotechnology company developing therapeutics, with programs focused on oncology.
BiotechHealthtechGaithersburg, US
Anthony D. Saleh, Ph.D.(CEO)inAnthony D. Saleh(CEO)inDave Lemus(COO/CFO)in
Co-investorsBoutique Venture PartnersBrown and White VenturesTachyon VenturesAlexandria
MODIFI provides a digital platform for cross-border trade finance, letting exporters and importers onboard online, receive payment right after shipping, and track trades and supplier payouts in one dashboard.
FintechLogistics & Supply ChainSaaSBainbridge Island, US
Jan Wehrs(Founder)inSven Brauer(Founder)inNelson Holzner(Co-Founder & CEO)inJames Poss(Executive Officer, Director, Promoter)Matthew Otepka(Executive Officer)J. Todd Larson(Executive Officer)
Co-investorsIncubate FundMaersk GrowthNeva Sgr.PICUS CAPITALGlobal Founders CapitalHighCape Capital
Modifi Bio presents itself as a research-focused biopharmaceutical company developing medicines and vaccines.
BiotechHealthtechNew Haven, US
Ranjit Bindra(Director)inKingson Lin(Cofounder)inKevin L. Rakin(Executive Officer, Director)in
BoardLucas de Breed(Director)Kat Kayser-Bricker(Director)
Co-investorsConnecticut InnovationsHighCape CapitalIronwood Capital
Nionyx develops gene therapies, focusing on the design of viral capsids, expression cassettes, and delivery systems for precision and safety.
BiotechDeep TechHealthtech
Co-investors2048 VenturesACADEMY INVESTORAIN Ventures
Ochre Bio develops RNA therapeutics and drug discovery platforms targeting liver disease, combining proprietary human liver datasets with AI-driven causal prediction and human tissue validation models.
AI & Machine LearningBiotechHealthtechMedical DevicesLondon, GB
Quin Wills(Founder/CSO)inJack O'Meara(Founding CEO)in
BoardChinwe UkomaduElaine SullivanEliot ForsterJack Castle
Co-investorsBackedBeast VenturesCoastCapEntrepreneur FirstExpaHoxton Ventures+7 more
Scioto Biosciences is a life sciences company with corporate offices and research facilities in Fishers, Indiana.
BiotechDeep TechDigital HealthIndianopolis, US
Joe Trebley(Founder & Chief Executive Officer)inJim Schulz(Founder & Chief Financial Officer)inMark Heiman(Chief Science Officer)inKevin Meyer(Chief Operating Officer)in
Co-investorsElevate VenturesIU VenturesMichigan Capital NetworkBioCrossroadsRev1 Ventures
Simergent develops medical device systems for regulated healthcare markets, with expertise in peritoneal dialysis and infusion pump technologies.
BiotechHealthtechMedical DevicesChicago, US
Steve J. Lindo(Co-founder & CEO)inRick Pendergraft(Co-founder & Chief Technology Officer)inDr. James Sloand(Chief Medical Officer)Michael Rohleder(Manager)
Co-investorsAngel Physicians FundPlains Ventures
AIRNA develops genetic medicines that use ADAR, a naturally occurring human protein, to precisely edit RNA and treat genetic diseases without permanently modifying DNA.
AI & Machine LearningBiotechDeep TechHealthtechStanford, US
Thorsten Stafforst(Chairman of the Board of Directors)inKris ElveruminTodd Bazemore(Chief Executive Officer)inJin (Billy) Li(Treasurer and Secretary)inPaul Vogel(Chief Executive Officer and President)in
BoardRodger Novak(Chair)in
Co-investors+ND CapitalARCH Venture PartnersForbionVenrockFast Track InitiativeNextech Invest+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
4BIOBioGraph 55Cytospire Therapeutics
Frequently asked questions
- How many investments has Pathway Bioventures made?
- Pathway Bioventures has 18 tracked investments, including 1 dated in the last 24 months.
- What stage does Pathway Bioventures invest at?
- Pathway Bioventures invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Pathway Bioventures focus on?
- Pathway Bioventures focuses on Biotech, Healthtech, Medical Devices.
- Where is Pathway Bioventures located?
- Pathway Bioventures is headquartered in Chicago, US.
- Who does Pathway Bioventures co-invest with?
- Pathway Bioventures most often shares deals with Tachyon Ventures, Entrepreneur First, Hoxton Ventures, among 66 tracked co-investors.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.